MARKET

DMRA

DMRA

DAMORA THERAPEUT
NASDAQ
20.78
-0.58
-2.72%
After Hours: 21.15 +0.37 +1.78% 17:31 06/12 EDT
OPEN
21.41
PREV CLOSE
21.36
HIGH
21.89
LOW
20.49
VOLUME
207.16K
TURNOVER
--
52 WEEK HIGH
38.33
52 WEEK LOW
2.450
MARKET CAP
1.28B
P/E (TTM)
-0.1469
1D
5D
1M
3M
1Y
5Y
1D
Damora Therapeutics Price Target Maintained With a $35.00/Share by Wedbush
Dow Jones · 1d ago
Wedbush Reiterates Outperform on Damora Therapeutics, Maintains $35 Price Target
Benzinga · 1d ago
Analysts Offer Insights on Healthcare Companies: Phibro Animal Health (PAHC) and Damora Therapeutics (DMRA)
TipRanks · 1d ago
Analysts’ Top Healthcare Picks: Enliven Therapeutics (ELVN), Invivyd (IVVD)
TipRanks · 1d ago
Damora Therapeutics publishes DMR-001 mutant calreticulin antibody presentation
PUBT · 2d ago
Damora Therapeutics Initiated at Buy by HC Wainwright & Co.
Dow Jones · 2d ago
Damora Therapeutics Price Target Announced at $45.00/Share by HC Wainwright & Co.
Dow Jones · 2d ago
HC Wainwright & Co. Initiates Coverage On Damora Therapeutics with Buy Rating, Announces Price Target of $45
Benzinga · 2d ago
More
About DMRA
Damora Therapeutics Inc, formerly Galecto, Inc, is a clinical-stage biotechnology company focused on the development of novel treatments for cancer and liver diseases. The Company is engaged in the advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is significant medical need for disease-modifying treatments. It offers a multiple programs including asset, DMR-001, an investigational monoclonal antibody therapy targeting mutCALR. DMR-001 was designed to exclusively bind to mutCALR with exquisite selectivity, potency, and extended half-life, with potential to enable convenient, infrequent subcutaneous dosing.

Webull offers Damora Therapeutics Inc stock information, including NASDAQ: DMRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DMRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DMRA stock methods without spending real money on the virtual paper trading platform.